Akanda (AKAN) vs Bon Natural Life (BON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bon Natural Life is the larger company by market cap ($9.5 million vs $4.7 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AKAN | BON |
|---|---|---|
| Share price | $1.78 | $1.17 |
| Market cap | $4.70M | $9.53M |
| 1-day change | -7.77% | +0.62% |
| Forward P/E | — | 2.01 |
| EPS (TTM) | $-14,935.32 | $-2.79 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $78.90 | $2.34 |
| 52-week low | $1.73 | $0.95 |
| Distance from 52-week high | -97.74% | -50.12% |
| Average volume | 1.35M | 7.99K |
| Shares outstanding | 2.39M | 6.13M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bon Natural Life is about 2.0 times larger than Akanda by market value ($9.53M vs $4.70M).
AKAN vs BON FAQ
Which is bigger, Akanda or Bon Natural Life?
Bon Natural Life (BON) is larger, with a market capitalization of $9.53M compared with $4.70M for Akanda (AKAN).
Are Akanda and Bon Natural Life in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.